Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Kanazawa University Research: Mapping and Measuring Proteins on the Surfaces of Endoplasmic Reticulum (ER) in Cells


KANAZAWA, Japan, 17 June, 2019 /PRNewswire/ -- Researchers from Kanazawa University on the development of a technique to closely track a specific protein on the surfaces of endoplasmic reticulum (ER) in cells. Their findings are published in Bioorganic and Medicinal Chemistry.

Sigma receptors are proteins found on mainly the surface of endoplasmic reticulum (ER) in certain cells. Sigma-1 and sigma-2 are the two main classes of these receptors. The sigma-1 receptor is involved neurological disorders and certain types of cancer. To understand better how the receptor is involved in disease and whether drugs developed to target it are working, it is important to be able to accurately trace the sigma-1 receptor. Researchers at Kanazawa University have developed a probe, which can identify and latch onto the sigma-1 receptor.

The research team led by Kazuma Ogawa had previously developed molecules with such binding potential. However, upon detailed analysis of the sigma-1 receptor structure, they realized that extending the length of these molecules would increase their binding affinity further. The team therefore created molecules with varying lengths and found one probe that bound to the receptor exceptionally well. For measuring and mapping the sigma receptors by nuclear imaging, radiolabeled iodine was introduced into the probe. The structure created subsequently bound to both sigma-1 and sigma-2 receptors.

Since sigma-1 and sigma-2 receptors are involved in prostate cancer, the team then tested the effects of their newly created molecular probe on prostate cancer cells. These cells have sigma receptors and thus any probe with a high affinity will attach to them and enter the cell. As expected, the probe signal from within the cell was high. When haloperidol?a drug specific to the sigma-1 receptor?was added to the mix this signal dropped, suggesting a competition between the two.

To finally assess the affinity of the probe for different tissues within the body, mice with prostatic tumors were used. While the probe easily entered and stayed within the tumors, its presence in the muscles and blood was less. The probe was thus highly specific for tissues with the presence of sigma receptors.

This study reports a sophisticated probe that binds to sigma-1 receptors better than previous probes developed. This coupled with its ability to escape non-specific tissues is a promising step forward in studying changes induced in the sigma-1 receptor in various disorders. The probe can also be used when developing drugs against the sigma-1 receptor to compare the binding affinities of such drugs. "These results provide useful information for developing sigma-1 receptor imaging probes", conclude the researchers.

Background

Sigma-1 receptor: Sigma-1 receptors were originally thought to interact with only opioids and related compounds. It is now known that there is a long list of chemical compounds with a high affinity for them. Sigma-1 receptors play a role in memory and recognition and are found within the nervous system and other tissues such as the heart and prostate gland. They are also known to be involved in several nervous system related disorders. Haloperidol, an anti-psychotic drug is one of the oldest and strongest binding partners of sigma-1 receptors.

Radiolabeling: Radiolabeling or isotope labelling is a tracking and imaging method used in medicine. A molecule is first structurally modified to introduce an isotope, an atom with a different mass, into it. These isotopes are usually unstable and emit a signal that can be measured easily. Thus, the location and quantity of the radiolabeled molecule can be tracked in the body based on the signal from the isotope. In this study, the researchers used the I-125 isotope of iodine, which is alternative isotope of I-123 for imaging safely to use in the human body.

Reference:

Kazuma Ogawa, Ryohei Masuda, Kenji Mishiro, Mengfei Wang, Takashi Kozaka, Kazuhiro Shiba, Seigo Kinuya, Akira Odani. Syntheses and evaluation of a homologous series of aza-vesamicol as improved radioiodine-labeled probes for sigma-1 receptor imaging. Bioorganic and Medicinal Chemistry, Volume 27, Issue 10, 15 May 2019, Pages 1990-1996, 2019.

https://doi.org/10.1016/j.bmc.2019.03.054

About Kanazawa University

As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949. The University has three colleges and 17 schools offering courses in subjects that include medicine, computer engineering, and humanities.

The University is located on the coast of the Sea of Japan in Kanazawa ? a city rich in history and culture. The city of Kanazawa has a highly respected intellectual profile since the time of the fiefdom (1598-1867). Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Kanazawa University website

http://www.kanazawa-u.ac.jp/e/

Further information:

Kanazawa University
Kakuma, Kanazawa, Ishikawa 920-1192, JAPAN
E-mail: [email protected]
Tel: +81(76) 264-5963

 

SOURCE Kanazawa University


These press releases may also interest you

at 08:15
MGI Tech, a company committed to building core tools and technology to lead life science, is proud to announce that its DNBSEQ-T20x2* gene sequencer has been recognized with a Gold Edison Award in the "Health, Medical & Biotech" category....

at 08:05
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company sought an extension of its previously announced stay of proceedings ("Stay") under the Companies' Creditors Arrangement Act (the "CCAA") at a hearing before the Ontario...

at 08:05
This partnership between Vertedge Health Analytics and InHome Connect utilizes data analytics to align patients in value-based care plans with palliative care services, aiming to improve patient care experiences, minimize unnecessary care...

at 08:03
Legacy Medical Consultants (LMC) announces its newest product portfolio addition with the recent Q code approval for Reeva FTtm, a terminally sterilized, full-thickness, dual-layered amnion/chorion allograft designed for covering and protection...

at 08:00
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for its revolutionary hemostatic gel, VETIGEL®, to be sold directly to...

at 08:00
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...



News published on and distributed by: